Agreement for psoriasis treatment

Posted on: Tuesday, August 20th, 2019

I reported previously (see here) on the small molecule treatments from Israel’s Can-Fite for psoriasis, liver and inflammatory diseases, and cancer. Can-Fite AND South Korea-based Kyongbo have just signed a distribution agreement for Can-Fite’s psoriasis treatment Piclidenoson (CF101).